Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa

被引：0
作者：
Jill Hanass-Hancock
Bradley Carpenter
Tarylee Reddy
Ayanda Nzuza
Zakir Gaffoor
Ameena Goga
Michele Andrasik
机构：
[1] South African Medical Research Council,HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
[2] Gender and Health Research Unit,undefined
[3] University of KwaZulu Natal School of Health Science,undefined
[4] South African Medical Research Council,undefined
[5] Biostatistics Research Unit,undefined
[6] South African Medical Research Council,undefined
[7] HIV Prevention Research Unit,undefined
[8] Fred Hutchinson Cancer Research Center,undefined
来源：
Trials | / 22卷
关键词：
HIV prevention; Clinical trials; HVTN; HIV vaccine; Research participation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 56 条
[1]  
McKinnon LR(2016)Factors Driving the HIV Epidemic in Southern Africa Curr HIV/AIDS Rep 13 158-169
[2]  
Karim QA(2019)A decade of sustained geographic spread of HIV infections among women in Durban, South Africa BMC Infect Dis 19 500-29
[3]  
Ramjee G(2012)HIV incidence remains high in KwaZulu-Natal, South Africa: evidence from three districts PLoS One 7 23-2132
[4]  
Sartorius B(2018)HIV vaccine clinical trials: an overview Medical Writing 27 2121-232
[5]  
Morris N(2016)Use of a Vaginal ring containing dapivirine for HIV-1 prevention in women N Engl J Med 375 226-ee78
[6]  
Nel A(2015)The current status of the use of oral medication to prevent HIV transmission Curr Opin HIV AIDS 10 e366-1100
[7]  
Mabude Z(2018)Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial Lancet HIV 5 1089-3211
[8]  
Smit J(2021)Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults N Engl J Med 384 3202-206
[9]  
Odhiambo J(2016)Combining biomedical preventions for HIV: vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions Hum Vaccin Immunother 12 198-364
[10]  
Baeten JM(2005)Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa Afr Health Sci 5 359-N2
123456